Matching slides 110,355
Current window 63,961-63,990
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all

Component

63,961-63,990 of 110,355

filter-aware
85
Includes citations at the bottom.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
86
The slide uses a structural biology diagram to explain the modularity of endolysins.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
88
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
96
The slide uses a biological process diagram to explain the mechanism of action and a branching logic diagram to explain the product portfolio strategy.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
97
The slide uses a circular process flow for the 5 steps and a feedback loop for the continuous platform evolution.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
101
The slide uses a process flow diagram to illustrate the current patient journey and outcomes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
104
Includes a pie chart of responder status and a line chart showing T-cell expansion over time, plus a summary table of median T-cell percentages.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
108
The slide uses a combination of metrics and a callout box to frame the clinical problem.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
112
The slide uses a swimmer plot to visualize disease-free survival and stacked bar charts for T-cell response rates.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
113
The slide uses a process flow diagram to illustrate the trial design.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
116
Includes binding affinity data and a biological mechanism diagram.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
118
Data cut-off: August 31, 2020. MTD not reached.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
120
Includes clinical trial data for BNT311; displays best change from baseline and longitudinal change over study weeks.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
06
The slide uses a chronological sequence of images and descriptive text to illustrate company growth.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations 1 hit
12
The slide uses a vertical timeline/growth arrow to visualize the increasing percentage of DTC revenue.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
13
The slide uses a stacked bar chart to compare internal revenue performance against external market opportunity.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
14
The table uses a hierarchical header structure to group APAC sub-regions.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
16
The slide uses a proprietary 'TEI' (Thermal Experience Index) framework to categorize products by temperature suitability.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
18
The slide uses a McKinsey survey to frame the problem, then pivots to company-specific advantages.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
21
The slide highlights financial performance metrics and provides a disclaimer regarding non-IFRS measures.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · Business ModelLoop · Cost Of Inaction1 hit
22
Includes specific financial targets for revenue, gross profit, EBIT, and net income per share, alongside qualitative assumptions regarding retail traffic and regional recovery.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · Business ModelLoop · Cost Of Inaction1 hit
07
Uses external citations (ABI, JAMA, CNBC) to establish credibility for the problem statement.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a laptop graphic to frame the primary chart. The data points are presented as a mix of a bar chart and a series of callout metrics.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
15
Includes CAGR calculations and guidance ranges for 2022E.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
16
Cano Health | Investor Day Presentation Deck | 105 slidesCano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
17
Cano Health | Investor Day Presentation Deck | 105 slidesCano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
22
Includes a map visualization of geographic footprint.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
24
The strategy is presented as a 'Build/Buy/Manage' framework.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
25
The chart uses a curve to represent increasing intensity across a spectrum of development types.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
26
Internal company illustrative estimates based on historical results.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit